What is he best known for?
The fields of study he is best known for:
- Dopamine
- Internal medicine
- Neurotransmitter
Gary E. Duncan mainly focuses on Neuroscience, NMDA receptor, Dopamine, Schizophrenia and Antipsychotic.
His work in the fields of Neuroscience, such as Nucleus accumbens, intersects with other areas such as Progressive disorder and Identification.
His research investigates the connection with NMDA receptor and areas like Pharmacology which intersect with concerns in Hippocampus and Ketamine.
The Dopamine portion of his research involves studies in Internal medicine and Endocrinology.
His Schizophrenia study integrates concerns from other disciplines, such as Psychosis and Neurotransmitter.
While the research belongs to areas of Antipsychotic, Gary E. Duncan spends his time largely on the problem of Clozapine, intersecting his research to questions surrounding Atypical antipsychotic and Haloperidol.
His most cited work include:
- Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs (766 citations)
- Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. (298 citations)
- Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity (214 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Endocrinology, Internal medicine, Pharmacology, Neuroscience and NMDA receptor.
In the field of Endocrinology, his study on Hippocampus, Central nervous system and Dopamine overlaps with subjects such as Imipramine.
Internal medicine and Binding site are commonly linked in his work.
His Pharmacology research incorporates elements of Clozapine, Haloperidol, Ketamine, Olanzapine and Antipsychotic.
Neuroscience is closely attributed to Schizophrenia in his work.
His NMDA receptor study combines topics from a wide range of disciplines, such as Glutamate receptor and Psychosis.
He most often published in these fields:
- Endocrinology (48.51%)
- Internal medicine (48.51%)
- Pharmacology (32.67%)
What were the highlights of his more recent work (between 2003-2012)?
- Pharmacology (32.67%)
- NMDA receptor (20.79%)
- Neuroscience (27.72%)
In recent papers he was focusing on the following fields of study:
His main research concerns Pharmacology, NMDA receptor, Neuroscience, Genetic model and Antipsychotic.
His Pharmacology study combines topics in areas such as Haloperidol, Clozapine, Olanzapine and Hippocampal formation.
He has researched NMDA receptor in several fields, including Glutamate receptor and Psychosis.
Within one scientific family, he focuses on topics pertaining to Prepulse inhibition under Psychosis, and may sometimes address concerns connected to Gating.
His Antipsychotic study contributes to a more complete understanding of Schizophrenia.
His studies in Schizophrenia integrate themes in fields like Dopamine receptor and Drug development, Drug.
Between 2003 and 2012, his most popular works were:
- Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs (766 citations)
- Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection (189 citations)
- Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. (173 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Dopamine
- Neurotransmitter
His primary areas of investigation include Psychosis, Schizophrenia, NMDA receptor, Neuroscience and Prepulse inhibition.
His Psychosis study frequently intersects with other fields, such as Pharmacology.
His Pharmacology research is multidisciplinary, incorporating elements of Aripiprazole and Dopamine receptor.
His research in the fields of Antipsychotic overlaps with other disciplines such as Mechanism of action.
His biological study spans a wide range of topics, including Discrimination learning and GRIN1.
His Prepulse inhibition research incorporates themes from Haloperidol, Clozapine and Gating.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
